From January 13th to January 16th, the J.P. Morgan Healthcare Conference will be held in San Francisco, USA. It is the largest and most influential event in the global healthcare industry, attracting top pharmaceutical companies, innovative companies, and investment professionals from around the world.
Sungening Biotechnology Chairman Huang Shenghong and Chief Technology Officer Dr. Chen Yan will go to the United States to participate in J P. Morgan Week - Biotech Showcase Conference. At the meeting, Dr. Chen Yan will introduce the company's pipeline and focus on announcing the clinical phase 1 data of the antifungal new drug SG1001 in collaboration with Lizhu, as well as the preclinical research results of the oral PCSK9 pipeline.
Sungening Biotechnology focuses on the research and development of new drugs in the field of cyclic peptides, with pipelines covering areas such as anti infection, metabolism, and oncology. It continues to promote overseas commercialization and actively seeks innovative drug cooperation. The company looks forward to taking this opportunity to have in-depth exchanges with global biopharmaceutical companies, investors, and research institutions, expand international cooperation, and enhance international influence.
We sincerely invite new and old friends to gather in San Francisco and explore innovative opportunities together!
Meeting time and location
Date: Monday, January 13，2025
Time: 14:30pm Track: Franciscan D (Ballroom Level)
Location：Hilton San Francisco Union Square, 333 O'Farrell Street, San Francisco, CA 94102
